2010 HCPCS Q0035 Cardiokymography2010 HCPCS Q0081 Infusion therapy, using other than chemotherapeutic drugs, per visit2010 HCPCS Q0083 Chemotherapy administration by other than infusion technique only (eg subcutaneous, intramuscular, push), per visit2010 HCPCS Q0084 Chemotherapy administration by infusion technique only, per visit2010 HCPCS Q0085 Chemotherapy administration by both infusion technique and other techique(s) (eg subcutaneous, intramuscular, push), per visit2010 HCPCS Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory2010 HCPCS Q0092 Set-up portable x-ray equipment2010 HCPCS Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens2010 HCPCS Q0112 All potassium hydroxide (koh) preparations2010 HCPCS Q0113 Pinworm examinations2010 HCPCS Q0114 Fern test2010 HCPCS Q0115 Post-coital direct, qualitative examinations of vaginal or cervical mucous2010 HCPCS Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)2010 HCPCS Q0139 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)2010 HCPCS Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram2010 HCPCS Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen2010 HCPCS Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0165 Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0166 Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen2010 HCPCS Q0167 Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0168 Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0170 Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0171 Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0172 Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0173 Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0174 Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0175 Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0176 Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0178 Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0179 Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0180 Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen2010 HCPCS Q0181 Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen2010 HCPCS Q0480 Driver for use with pneumatic ventricular assist device, replacement only2010 HCPCS Q0481 Microprocessor control unit for use with electric ventricular assist device, replacement only2010 HCPCS Q0482 Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only2010 HCPCS Q0483 Monitor/display module for use with electric ventricular assist device, replacement only2010 HCPCS Q0484 Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0485 Monitor control cable for use with electric ventricular assist device, replacement only2010 HCPCS Q0486 Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0487 Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0488 Power pack base for use with electric ventricular assist device, replacement only2010 HCPCS Q0489 Power pack base for use with electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0490 Emergency power source for use with electric ventricular assist device, replacement only2010 HCPCS Q0491 Emergency power source for use with electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0492 Emergency power supply cable for use with electric ventricular assist device, replacement only2010 HCPCS Q0493 Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0494 Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0495 Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0496 Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0497 Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0498 Holster for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0499 Belt/vest for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0500 Filters for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0501 Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0502 Mobility cart for pneumatic ventricular assist device, replacement only2010 HCPCS Q0503 Battery for pneumatic ventricular assist device, replacement only, each2010 HCPCS Q0504 Power adapter for pneumatic ventricular assist device, replacement only, vehicle type2010 HCPCS Q0505 Miscellaneous supply or accessory for use with ventricular assist device2010 HCPCS Q0506 Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only2010 HCPCS Q0510 Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant2010 HCPCS Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period2010 HCPCS Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period2010 HCPCS Q0513 Pharmacy dispensing fee for inhalation drug(s); per 30 days2010 HCPCS Q0514 Pharmacy dispensing fee for inhalation drug(s); per 90 days2010 HCPCS Q0515 Injection, sermorelin acetate, 1 microgram2010 HCPCS Q1003 New technology intraocular lens category 3 (reduced spherical aberration)2010 HCPCS Q1004 New technology intraocular lens category 4 as defined in federal register notice2010 HCPCS Q1005 New technology intraocular lens category 5 as defined in federal register notice2010 HCPCS Q2004 Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml2010 HCPCS Q2009 Injection, fosphenytoin, 50 mg phenytoin equivalent2010 HCPCS Q2017 Injection, teniposide, 50 mg2010 HCPCS Q2023 TERMINATED 12/31/2009 : Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.2010 HCPCS Q2024 TERMINATED 12/31/2009 : Injection, bevacizumab, 0.25 mg2010 HCPCS Q3001 Radioelements for brachytherapy, any type, each2010 HCPCS Q3014 Telehealth originating site facility fee2010 HCPCS Q3019 TERMINATED 3/31/2006 : Als vehicle used, emergency transport, no als level services furnished2010 HCPCS Q3020 TERMINATED 3/31/2006 : Als vehicle used, non-emergency transport, no als level service furnished2010 HCPCS Q3025 Injection, interferon beta-1a, 11 mcg for intramuscular use2010 HCPCS Q3026 Injection, interferon beta-1a, 11 mcg for subcutaneous use2010 HCPCS Q3031 Collagen skin test2010 HCPCS Q4001 Casting supplies, body cast adult, with or without head, plaster2010 HCPCS Q4002 Cast supplies, body cast adult, with or without head, fiberglass2010 HCPCS Q4003 Cast supplies, shoulder cast, adult (11 years +), plaster2010 HCPCS Q4004 Cast supplies, shoulder cast, adult (11 years +), fiberglass2010 HCPCS Q4005 Cast supplies, long arm cast, adult (11 years +), plaster2010 HCPCS Q4006 Cast supplies, long arm cast, adult (11 years +), fiberglass2010 HCPCS Q4007 Cast supplies, long arm cast, pediatric (0-10 years), plaster2010 HCPCS Q4008 Cast supplies, long arm cast, pediatric (0-10 years), fiberglass2010 HCPCS Q4009 Cast supplies, short arm cast, adult (11 years +), plaster2010 HCPCS Q4010 Cast supplies, short arm cast, adult (11 years +), fiberglass2010 HCPCS Q4011 Cast supplies, short arm cast, pediatric (0-10 years), plaster2010 HCPCS Q4012 Cast supplies, short arm cast, pediatric (0-10 years), fiberglass2010 HCPCS Q4013 Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster2010 HCPCS Q4014 Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass2010 HCPCS Q4015 Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster2010 HCPCS Q4016 Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass2010 HCPCS Q4017 Cast supplies, long arm splint, adult (11 years +), plaster2010 HCPCS Q4018 Cast supplies, long arm splint, adult (11 years +), fiberglass2010 HCPCS Q4019 Cast supplies, long arm splint, pediatric (0-10 years), plaster2010 HCPCS Q4020 Cast supplies, long arm splint, pediatric (0-10 years), fiberglass2010 HCPCS Q4021 Cast supplies, short arm splint, adult (11 years +), plaster2010 HCPCS Q4022 Cast supplies, short arm splint, adult (11 years +), fiberglass2010 HCPCS Q4023 Cast supplies, short arm splint, pediatric (0-10 years), plaster2010 HCPCS Q4024 Cast supplies, short arm splint, pediatric (0-10 years), fiberglass2010 HCPCS Q4025 Cast supplies, hip spica (one or both legs), adult (11 years +), plaster2010 HCPCS Q4026 Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass2010 HCPCS Q4027 Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster2010 HCPCS Q4028 Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass2010 HCPCS Q4029 Cast supplies, long leg cast, adult (11 years +), plaster2010 HCPCS Q4030 Cast supplies, long leg cast, adult (11 years +), fiberglass2010 HCPCS Q4031 Cast supplies, long leg cast, pediatric (0-10 years), plaster2010 HCPCS Q4032 Cast supplies, long leg cast, pediatric (0-10 years), fiberglass2010 HCPCS Q4033 Cast supplies, long leg cylinder cast, adult (11 years +), plaster2010 HCPCS Q4034 Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass2010 HCPCS Q4035 Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster2010 HCPCS Q4036 Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass2010 HCPCS Q4037 Cast supplies, short leg cast, adult (11 years +), plaster2010 HCPCS Q4038 Cast supplies, short leg cast, adult (11 years +), fiberglass2010 HCPCS Q4039 Cast supplies, short leg cast, pediatric (0-10 years), plaster2010 HCPCS Q4040 Cast supplies, short leg cast, pediatric (0-10 years), fiberglass2010 HCPCS Q4041 Cast supplies, long leg splint, adult (11 years +), plaster2010 HCPCS Q4042 Cast supplies, long leg splint, adult (11 years +), fiberglass2010 HCPCS Q4043 Cast supplies, long leg splint, pediatric (0-10 years), plaster2010 HCPCS Q4044 Cast supplies, long leg splint, pediatric (0-10 years), fiberglass2010 HCPCS Q4045 Cast supplies, short leg splint, adult (11 years +), plaster2010 HCPCS Q4046 Cast supplies, short leg splint, adult (11 years +), fiberglass2010 HCPCS Q4047 Cast supplies, short leg splint, pediatric (0-10 years), plaster2010 HCPCS Q4048 Cast supplies, short leg splint, pediatric (0-10 years), fiberglass2010 HCPCS Q4049 Finger splint, static2010 HCPCS Q4050 Cast supplies, for unlisted types and materials of casts2010 HCPCS Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)2010 HCPCS Q4074 Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms2010 HCPCS Q4079 TERMINATED 12/31/2007 : Injection, natalizumab, 1 mg2010 HCPCS Q4080 TERMINATED 12/31/2009 : Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms2010 HCPCS Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis)2010 HCPCS Q4082 Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)2010 HCPCS Q4083 TERMINATED 12/31/2007 : Hyaluronan or derivative, hyalgan or supartz, for intra-articular injection, per dose2010 HCPCS Q4084 TERMINATED 12/31/2007 : Hyaluronan or derivative, synvisc, for intra-articular injection, per dose2010 HCPCS Q4085 TERMINATED 12/31/2007 : Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose2010 HCPCS Q4086 TERMINATED 12/31/2007 : Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose2010 HCPCS Q4087 TERMINATED 12/31/2007 : Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g. liquid), 500 mg2010 HCPCS Q4088 TERMINATED 12/31/2007 : Injection, immune globulin, (gammagard liquid), intravenous, non-lyophilized, (e.g. liquid), 500 mg2010 HCPCS Q4089 TERMINATED 12/31/2007 : Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu2010 HCPCS Q4090 TERMINATED 12/31/2007 : Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml2010 HCPCS Q4091 TERMINATED 12/31/2007 : Injection, immune globulin, (flebogamma), intravenous, non-lyophilized, (e.g. liquid), 500 mg2010 HCPCS Q4092 TERMINATED 12/31/2007 : Injection, immune globulin, (gamunex), intravenous, non-lyophilized (e.g. liquid), 500 mg2010 HCPCS Q4093 TERMINATED 12/31/2007 : Albuterol, all formulations including separated isomers, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 1 mg (albuterol) or per 0.5 mg (levalbuterol)2010 HCPCS Q4094 TERMINATED 12/31/2007 : Albuterol, all formulations including separated isomers, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, per 1 mg (albuterol) or per 0.5 mg (levalbuterol)2010 HCPCS Q4095 TERMINATED 12/31/2007 : Injection, zoledronic acid (reclast), 1 mg2010 HCPCS Q4096 TERMINATED 12/31/2008 : Injection, von willebrand factor complex, human, ristocetin cofactor (not otherwise specified), per i.u. vwf: rco2010 HCPCS Q4097 TERMINATED 12/31/2008 : Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g. liquid), 500 mg2010 HCPCS Q4098 TERMINATED 12/31/2008 : Injection, iron dextran, 50 mg2010 HCPCS Q4099 TERMINATED 12/31/2008 : Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms2010 HCPCS Q4100 Skin substitute, not otherwise specified2010 HCPCS Q4101 Skin substitute, apligraf, per square centimeter2010 HCPCS Q4102 Skin substitute, oasis wound matrix, per square centimeter2010 HCPCS Q4103 Skin substitute, oasis burn matrix, per square centimeter2010 HCPCS Q4104 Skin substitute, integra bilayer matrix wound dressing (bmwd), per square centimeter2010 HCPCS Q4105 Skin substitute, integra dermal regeneration template (drt), per square centimeter2010 HCPCS Q4106 Skin substitute, dermagraft, per square centimeter2010 HCPCS Q4107 Skin substitute, graftjacket, per square centimeter2010 HCPCS Q4108 Skin substitute, integra matrix, per square centimeter2010 HCPCS Q4109 Skin substitute, tissuemend, per square centimeter2010 HCPCS Q4110 Skin substitute, primatrix, per square centimeter2010 HCPCS Q4111 Skin substitute, gammagraft, per square centimeter2010 HCPCS Q4112 Allograft, cymetra, injectable, 1cc2010 HCPCS Q4113 Allograft, graftjacket express, injectable, 1cc2010 HCPCS Q4114 Integra flowable wound matrix, injectable, 1cc2010 HCPCS Q4115 Skin substitute, alloskin, per square centimeter2010 HCPCS Q4116 Skin substitute, alloderm, per square centimeter2010 HCPCS Q5001 Hospice care provided in patient's home/residence2010 HCPCS Q5002 Hospice care provided in assisted living facility2010 HCPCS Q5003 Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)2010 HCPCS Q5004 Hospice care provided in skilled nursing facility (snf)2010 HCPCS Q5005 Hospice care provided in inpatient hospital2010 HCPCS Q5006 Hospice care provided in inpatient hospice facility2010 HCPCS Q5007 Hospice care provided in long term care facility2010 HCPCS Q5008 Hospice care provided in inpatient psychiatric facility2010 HCPCS Q5009 Hospice care provided in place not otherwise specified (nos)2010 HCPCS Q9945 TERMINATED 12/31/2007 : Low osmolar contrast material, up to 149 mg/ml iodine concentration, per ml2010 HCPCS Q9946 TERMINATED 12/31/2007 : Low osmolar contrast material, 150-199 mg/ml iodine concentration, per ml2010 HCPCS Q9947 TERMINATED 12/31/2007 : Low osmolar contrast material, 200-249 mg/ml iodine concentration, per ml2010 HCPCS Q9948 TERMINATED 12/31/2007 : Low osmolar contrast material, 250-299 mg/ml iodine concentration, per ml2010 HCPCS Q9949 TERMINATED 12/31/2007 : Low osmolar contrast material, 300-349 mg/ml iodine concentration, per ml2010 HCPCS Q9950 TERMINATED 12/31/2007 : Low osmolar contrast material, 350-399 mg/ml iodine concentration, per ml2010 HCPCS Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml2010 HCPCS Q9952 TERMINATED 12/31/2007 : Injection, gadolinium-based magnetic resonance contrast agent, per ml2010 HCPCS Q9953 Injection, iron-based magnetic resonance contrast agent, per ml2010 HCPCS Q9954 Oral magnetic resonance contrast agent, per 100 ml2010 HCPCS Q9955 Injection, perflexane lipid microspheres, per ml2010 HCPCS Q9956 Injection, octafluoropropane microspheres, per ml2010 HCPCS Q9957 Injection, perflutren lipid microspheres, per ml2010 HCPCS Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml2010 HCPCS Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml2010 HCPCS Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml2010 HCPCS Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml2010 HCPCS Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml2010 HCPCS Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml2010 HCPCS Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml2010 HCPCS Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml2010 HCPCS Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml2010 HCPCS Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml2010 HCPCS Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
